Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitebaycitycapital.com
Phone415.676.3830
Employees
Founded1997

Funds

Offices

San Francisco, USA
750 Battery Street Suite 400
San Francisco, CA, 94111
USA

People

Partner
Partner
Partner
Partner
Venture Partner
Venture Partner
Investment Partner
Investment Partner
Show All People

Tags

Bay City Capital

Bay City Capital LLC (Bay City Capital) was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed six venture funds representing $1.5 billion in capital invested in over 70 companies. Five of these funds are general life sciences funds, and one is a nutrition and agribusiness sector fund.

Recent Milestones

Investments

Company Date Round Size Participants
Omicia 1/2014Series A$6.8M5
PharmAkea Therapeutics 10/2013Series A$10M1
Merus 10/2013Series B€31M5
Cydan 10/2013Venture Round$10M4
TRIA Beauty 7/2013Private Equity$45.5M7
Aviir 6/2013Series B$10M4
Dermira 6/2013Series B$35M4
Nabsys 3/2013Series D$35M3
Nevro 3/2013Series C$48M9
Aviir 2/2013Series B$10M4
SynGen 4/2012Series A$5M1
Altheos 2/2012Series A$12.5M3
Aviir 12/2011Series B$10M4
Dermira 10/2011Series A$42M3
Nevro 7/2011Venture Round$58M7
Aviir 6/2011Venture Round$3M3
Conatus Pharmaceuticals 2/2011Series B$20M6
NextWave Pharmaceuticals 1/2011Series C$45M7
IDEV Technologies 10/2010Series D$46M5
Altheos 4/2010Series A$20M5
Merus 1/2010Series B€21.7M4
Aviir 1/2010Venture Round$4.2M3
CymaBay Therapeutics 11/2009Venture Round$8.6M12
Calypso Medical 11/2009Series E$50M4
Aviir 10/2009Venture Round$1M3
Epizyme 10/2009Series B$32M5
Aviir 8/2009Venture Round$1M3
Sunesis Pharmaceuticals 4/2009Venture Round$43.5M9
VIA Pharmaceuticals 3/2009Debt$10M1
Aviir 12/2008Venture Round$7.8M3
BrainCells 3/2008Series B$30M6
Aragon Surgical 1/2008Series B$25M4
Aviir 9/2007Venture Round$11.4M3
Presidio Pharmaceuticals 8/2007Series B$26M5
Vivaldi Biosciences 5/2007Series A$2M1
CymaBay Therapeutics 4/2007Series D$32M16
MAP Pharmaceuticals 3/2007Series D$50M6
Phenomix 3/2007Series C$55M10
PTC Therapeutics 11/2005Private Equity$26.6M9
Epocrates 8/2002Series C5
Epocrates 8/2000Series B$35M5

Videos

Sources

  1. Omicia Closes $6.8M Series A Financing (finsmes.com) [edit]
  2. PharmAkea Therapeutics raises Series A financing (finsmes.com) [edit]
  3. Merus Raises €31M in Series B Financing (finsmes.com) [edit]
  4. Cydan Raises $10M Funding (finsmes.com) [edit]
  5. Tria Beauty Closes $90.5M Equity-Debt Round for Cosmetic Laser Devices (pevc.dowjones.com) [edit]
  6. Aviir Raises Additional $10M (finsmes.com) [edit]
  7. Dermira Raises $35m to Fund Innovation in Dermatology (businesswire.com) [edit]
  8. SEC (sec.gov) [edit]
  9. Nevro Raises $48M in Series C Financing (finsmes.com) [edit]
  10. Aviir Snags $10M In Second Tranche Financing (socaltech.com) [edit]
  11. SynGen Inc. Receives $5 million Equity Investment from Bay City Capital, LLC (bizjournals.com) [edit]
  12. Altheos grabs $12.5M more, launches glaucoma trial (fiercebiotech.com) [edit]
  13. Aviir Seals Agreement for Up to $30M in Funding (pehub.com) [edit]
  14. Dermira Raises $42M in Series A Funding (finsmes.com) [edit]
  15. Nevro Completes $58M Financing (finsmes.com) [edit]
  16. SEC (sec.gov) [edit]
  17. Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing (pharmalive.com) [edit]
  18. NextWave Pharmaceuticals Raises $45m in a Series C Financing (finsmes.com) [edit]
  19. IDEV Technologies Completes $46M Series D Financing (finsmes.com) [edit]
  20. Glaucoma drug focus inspires $20M A round for Altheos (fiercebiotech.com) [edit]
  21. Merus closes EUR 21.7 million Series B financing and enters option agreement with the Novartis Option Fund (merus.nl) [edit]
  22. Aviir diagnoses heart conditions with new $4.2M (venturebeat.com) [edit]
  23. Metabolex (Metabolex.com) [edit]
  24. Calypso Medical Technologies, Inc.: Series E $50M (onbiovc.com) [edit]
  25. Aviir pumps up with $1M for heart diagnostics (venturebeat.com) [edit]
  26. Epizyme pulls in $32M in VC capital, new investors (fiercebiotech.com) [edit]
  27. SEC Filing (sec.gov) [edit]
  28. VCs PIPE $43.5 Million to Sunesis Pharma (pehub.com) [edit]
  29. VIA Pharmaceuticals nabs loan for cardiovascular treatment (venturebeat.com) [edit]
  30. Aviir pumps in $7.8M for heart diagnostics (venturebeat.com) [edit]
  31. BrainCells raises $30M (venturebeat.com) [edit]
  32. ARAGON SURGICAL SECURES $25 MILLION IN SERIES B FINANCING (aragonsurgical.com) [edit]
  33. Heart-diagnostic maker Aviir raises $11.3M (venturebeat.com) [edit]
  34. Presidio Pharmaceuticals Closes $26 Million Series B Financing (presidiopharma.com) [edit]
  35. Vivaldi Biosciences scoops up $2M for flu vaccines (venturebeat.com) [edit]
  36. Metabolex (Metabolex.com) [edit]
  37. MAP Pharma raises $50M for respiratory and CNS disease treatments (venturebeat.com) [edit]
  38. PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING (phenomixcorp.com) [edit]
  39. PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING (ptct.client.shareholder.com) [edit]
  40. otohns.net [edit]
  41. epocrates.com [edit]
Edit This Page
Last Edited 3/8/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy